Literature DB >> 6442499

Physicochemical and immunological characterization of meningococcal group A polysaccharide-tetanus toxoid conjugates prepared by two methods.

E C Beuvery, A vd Kaaden, V Kanhai, A B Leussink.   

Abstract

Two methods have been applied for the covalent binding of high molecular weight Neisseria meningitidis group A polysaccharide to tetanus toxoid. The first method used cyanogen bromide as the coupling reagent and the second used both glycine and 6-amino-n-hexanoic acid as spacers and N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as the coupling reagent. Each conjugation was performed twice. The conjugates were analysed by biochemical, physicochemical and immunochemical techniques. The immunogenic activities of the conjugates were studied in mice. The IgG responses to both components of the conjugates were measured by the enzyme-linked immunosorbent assay (ELISA). After the first dose differences in immunogenic activity of the tetanus toxoid component of the conjugates were seen, whereas after the second dose differences in activity of the polysaccharide component were observed. The second dose of all conjugates produced clear booster effects in the responses to both components. AlPO4 potentiated both the primary antibody responses and did not influence the booster effects. These data indicate that both components of the conjugates behaved as thymic-dependent immunogens. The second method of preparation resulted in conjugates with higher immunogenic activities. Significant differences in activity, however, were seen between conjugates prepared by the same method. These data indicate that the reproducibility of the method of preparation needs further consideration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6442499     DOI: 10.1016/0264-410x(83)90010-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Vaccines for prevention of meningococcal disease.

Authors:  C E Frasch
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

2.  Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.

Authors:  D Martin; N Cadieux; J Hamel; B R Brodeur
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

3.  Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.

Authors:  Zhigang Jin; Chiayung Chu; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 4.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03

5.  Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.

Authors:  Francesca Micoli; Maria Rosaria Romano; Marta Tontini; Emilia Cappelletti; Massimiliano Gavini; Daniela Proietti; Simona Rondini; Erwin Swennen; Laura Santini; Sara Filippini; Cristiana Balocchi; Roberto Adamo; Gerd Pluschke; Gunnstein Norheim; Andrew Pollard; Allan Saul; Rino Rappuoli; Calman A MacLennan; Francesco Berti; Paolo Costantino
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

6.  Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates.

Authors:  X X Gu; C M Tsai
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 7.  Technical Development of a New Meningococcal Conjugate Vaccine.

Authors:  Carl E Frasch; Subhash V Kapre; Che-Hung Lee; Jean-Marie Préaud
Journal:  Clin Infect Dis       Date:  2015-11-15       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.